https://lifecodexx.com/eurofins-lifecodexx/presse/ https://lifecodexx.com/gatc-biotech-und-lifecodexx-entwickeln-diagnostischen-test-zur-frueherkennung-von-praeeklampsie/ 2015-03-19T12:43:26+01:00 https://lifecodexx.com/gatc-biotech-und-lifecodexx-beenden-rekrutierung-von-ueber-500-blutproben-fuer-klinische-studie-des-trisomie-21-diagnostiktests/ 2015-03-19T14:15:15+01:00 https://lifecodexx.com/lifecodexx-schliesst-klinische-validierung-der-nicht-invasiven-methode-zum-nachweis-von-trisomie-21-erfolgreich-ab/ 2015-03-19T14:29:04+01:00 https://lifecodexx.com/praenatest-erfuellt-alle-gesetzlichen-vorgaben-und-ist-verfassungskonform/ 2015-03-19T14:34:50+01:00 https://lifecodexx.com/praenatest-jetzt-in-deutschland-oesterreich-liechtenstein-und-in-der-schweiz-verfuegbar/ 2015-03-19T14:38:05+01:00 https://lifecodexx.com/rund-1000-frauen-haben-sich-seit-markteinfuehrung-bereits-fuer-den-praenatest-entschieden/ 2015-03-19T17:01:20+01:00 https://lifecodexx.com/praenatest-jetzt-zur-bestimmung-der-fetalen-trisomien-21-18-und-13-weltweit-erste-klinische-nachbeobachtungsstudie-des-nicht-invasiven-molekulargenetischen-verfahrens-gestartet/ 2015-03-19T17:09:25+01:00 https://lifecodexx.com/erste-konsensusempfehlung-zum-einsatz-nicht-invasiver-praenataltests-aus-muetterlichem-blut-nipt/ 2015-03-19T17:19:54+01:00 https://lifecodexx.com/who-else-wants-converio-theme/ 2015-03-20T13:07:30+01:00 https://lifecodexx.com/erfolgreiche-pilotstudie-fuer-nicht-invasiven-praenatalen-diagnostiktest-zur-bestimmung-von-trisomie-21/ 2015-03-20T13:08:35+01:00 https://lifecodexx.com/gatc-biotech-und-lifecodexx-entwickeln-diagnostischen-test-zur-frueherkennung-von-praeeklampsie/ 2015-03-20T13:09:38+01:00 https://lifecodexx.com/erfolgreicher-start-der-klinischen-validierungsstudie-fuer-nicht-invasiven-praenatalen-diagnostiktest-zur-bestimmung-von-trisomie-21/ 2015-03-20T13:10:25+01:00 https://lifecodexx.com/sequenom-gibt-europaeischen-lizenzvertrag-mit-gatc-tochter-lifecodexx-bekannt/ 2015-03-20T13:15:44+01:00 https://lifecodexx.com/gatc-biotech-und-lifecodexx-beenden-rekrutierung-von-ueber-500-blutproben-fuer-klinische-studie-des-trisomie-21-diagnostiktests/ 2015-03-20T13:19:29+01:00 https://lifecodexx.com/lifecodexx-schliesst-klinische-validierung-der-nicht-invasiven-methode-zum-nachweis-von-trisomie-21-erfolgreich-ab/ 2015-03-20T13:29:00+01:00 https://lifecodexx.com/rund-1000-frauen-haben-sich-seit-markteinfuehrung-bereits-fuer-den-praenatest-entschieden/ 2015-03-20T13:34:03+01:00 https://lifecodexx.com/praenatest-jetzt-in-deutschland-oesterreich-liechtenstein-und-in-der-schweiz-verfuegbar/ 2015-03-20T13:38:25+01:00 https://lifecodexx.com/praenatest-jetzt-in-ueber-30-laendern-in-europa-asien-und-im-nahen-osten-verfuegbar/ 2015-03-20T13:43:37+01:00 https://lifecodexx.com/praenatest-jetzt-zur-bestimmung-der-fetalen-trisomien-21-18-und-13-weltweit-erste-klinische-nachbeobachtungsstudie-des-nicht-invasiven-molekulargenetischen-verfahrens-gestartet/ 2015-03-20T14:15:08+01:00 https://lifecodexx.com/mit-dem-neuen-praenatestexpress-erhalten-risikoschwangere-das-testergebnis-bereits-innerhalb-einer-woche/ 2015-03-20T14:45:08+01:00 https://lifecodexx.com/neue-studie-belegt-klinischen-nutzen-praenatest-reduziert-die-zahl-der-invasiven-praenataldiagnostischen-eingriffe-um-fast-70/ 2015-03-20T15:01:24+01:00 https://lifecodexx.com/lifecodexx-expands-its-praenatest-spectrum-and-reports-positive-reimbursement-decision-in-germany/ 2015-03-20T15:17:53+01:00 https://lifecodexx.com/lifecodexx-ag-meldet-erfolgreichen-proof-of-principle-eines-innovativen-pcr-basierten-nipt-assays/ 2015-03-26T11:15:50+01:00 https://lifecodexx.com/lifecodexx-ag-meldet-erfolgreichen-proof-of-principle-eines-innovativen-pcr-basierten-nipt-assays/ 2015-03-26T13:54:33+01:00 https://lifecodexx.com/?p=4604 2015-04-22T13:40:40+02:00 https://lifecodexx.com/praenatest-in-der-schweiz-jetzt-aus-helsanas-privater-zusatzversicherung-primeo-verguetet/ 2015-06-16T09:27:48+02:00 https://lifecodexx.com/praenatest-in-der-schweiz-jetzt-aus-helsanas-privater-zusatzversicherung-primeo-verguetet/ 2015-06-16T09:31:21+02:00 https://lifecodexx.com/mit-dem-neuen-praenatestexpress-erhalten-risikoschwangere-das-testergebnis-bereits-innerhalb-einer-woche/ 2015-06-16T09:31:49+02:00 https://lifecodexx.com/praenatest-jetzt-in-ueber-30-laendern-in-europa-asien-und-im-nahen-osten-verfuegbar/ 2015-06-16T09:32:15+02:00 https://lifecodexx.com/sequenom-gibt-europaeischen-lizenzvertrag-mit-gatc-tochter-lifecodexx-bekannt/ 2015-06-16T09:32:42+02:00 https://lifecodexx.com/erfolgreicher-start-der-klinischen-validierungsstudie-fuer-nicht-invasiven-praenatalen-diagnostiktest-zur-bestimmung-von-trisomie-21/ 2015-06-16T09:33:11+02:00 https://lifecodexx.com/erfolgreiche-pilotstudie-fuer-nicht-invasiven-praenatalen-diagnostiktest-zur-bestimmung-von-trisomie-21/ 2015-06-16T09:33:44+02:00 https://lifecodexx.com/who-else-wants-converio-theme/ 2015-06-16T09:34:15+02:00 https://lifecodexx.com/praenatest-in-der-schweiz-jetzt-aus-helsanas-privater-zusatzversicherung-primeo-verguetet/ 2015-07-06T15:15:22+02:00 https://lifecodexx.com/en/prenatest-is-now-paid-for-by-swiss-statutory-health-insurance-programs/ 2015-07-07T15:06:29+02:00 https://lifecodexx.com/praenatest-jetzt-von-gesetzlichen-krankenkassen-in-der-schweiz-bezahlt/ 2015-07-07T15:40:10+02:00 https://lifecodexx.com/it/prenatest-is-now-reimbursed-by-swiss-statutory-health-insurance-programs/ 2015-07-10T14:20:56+02:00 https://lifecodexx.com/fr/prenatest-is-now-reimbursed-by-swiss-statutory-health-insurance-programs/ 2015-10-05T14:46:27+02:00 https://lifecodexx.com/erfolgreiche-klinische-validierung-des-neuen-qpcr-basierten-praenatest/ 2015-12-01T10:35:53+01:00 https://lifecodexx.com/en/novel-qpcr-based-prenatest-successfully-validated-in-clinical-study/ 2015-12-01T10:37:46+01:00 https://lifecodexx.com/fr/novel-qpcr-based-prenatest-successfully-validated-in-clinical-study/ 2015-12-01T10:40:05+01:00 https://lifecodexx.com/it/novel-qpcr-based-prenatest-successfully-validated-in-clinical-study/ 2015-12-01T10:41:42+01:00 https://lifecodexx.com/fr/lifecodexx-ag-enhances-prenatest-availability-in-switzerland-and-germany-through-successful-technology-transfers-and-strategic-partnerships/ 2016-03-16T08:40:50+01:00 https://lifecodexx.com/it/lifecodexx-ag-enhances-prenatest-availability-in-switzerland-and-germany-through-successful-technology-transfers-and-strategic-partnerships/ 2016-03-16T08:43:05+01:00 https://lifecodexx.com/elucigene-diagnostics-and-lifecodexx-partner-to-offer-nipt-in-uk-and-ireland/ 2016-10-28T08:16:03+02:00 https://lifecodexx.com/elucigene-diagnostics-and-lifecodexx-partner-to-offer-nipt-in-uk-and-ireland/ 2016-10-28T09:04:12+02:00 https://lifecodexx.com/en/lifecodexx-receives-ce-mark-for-its-novel-nipt-solution-based-on-methylation-specific-quantitative-pcr/ 2016-12-20T11:18:03+01:00 https://lifecodexx.com/sengenics-and-lifecodexx-partner-to-offer-nipt-in-southeast-asia/ 2017-01-03T08:35:09+01:00 https://lifecodexx.com/sengenics-and-lifecodexx-partner-to-offer-nipt-in-southeast-asia/ 2017-01-03T08:35:31+01:00 https://lifecodexx.com/praenatest-einen-schritt-naeher-an-kassenerstattung/ 2017-04-04T12:32:18+02:00 https://lifecodexx.com/lifecodexx-erhaelt-ce-zulassung-fuer-neue-nipt-loesung-basierend-auf-quantitativer-pcr/ 2017-04-04T16:04:59+02:00 https://lifecodexx.com/lifecodexx-ag-includes-digeorge-syndrome-into-prenatest-spectrum-in-clinical-routine/ 2017-04-05T10:22:38+02:00 https://lifecodexx.com/prospektive-klinische-nachbeobachtungsstudie-mit-ueber-2-200-patientinnen-bestaetigt-hohe-testgenauigkeit-des-praenatest-bei-fetalen-trisomien/ 2017-04-05T11:21:09+02:00 https://lifecodexx.com/lifecodexx-ag-enhances-prenatest-availability-in-switzerland-and-germany-through-successful-technology-transfers-and-strategic-partnerships/ 2017-04-05T11:35:21+02:00 https://lifecodexx.com/lifecodexx-ag-und-mgz-muenchen-schliessen-kooperationsvertrag-zur-durchfuehrung-des-praenatest-in-muenchen/ 2017-04-05T14:20:37+02:00 https://lifecodexx.com/lifecodexx-ag-staerkt-fuehrende-marktposition-in-deutschland-durch-strategische-partnerschaft-mit-der-limbach-gruppe-se/ 2017-04-05T14:22:56+02:00 https://lifecodexx.com/erster-technologietransfer-des-praenatest-zum-labor-dr-wisplinghoff-in-koeln-erfolgreich-abgeschlossen/ 2017-04-05T14:47:35+02:00 https://lifecodexx.com/neue-studie-belegt-klinischen-nutzen-praenatest-reduziert-die-zahl-der-invasiven-praenataldiagnostischen-eingriffe-um-fast-70/ 2017-04-05T15:18:18+02:00 https://lifecodexx.com/en/prospective-clinical-follow-up-study-with-over-2200-patients-confirms-high-test-accuracy-of-prenatest-for-fetal-trisomies/ 2017-04-06T11:57:45+02:00 https://lifecodexx.com/lifecodexx-ag-includes-digeorge-syndrome-into-prenatest-spectrum-in-clinical-routine/ 2017-04-06T12:00:02+02:00 https://lifecodexx.com/praenatest-einen-schritt-naeher-an-kassenerstattung/ 2017-04-06T12:02:54+02:00 https://lifecodexx.com/en/lifecodexx-ag-enhances-prenatest-availability-in-switzerland-and-germany-through-successful-technology-transfers-and-strategic-partnerships/ 2017-04-06T13:51:13+02:00 https://lifecodexx.com/en/lifecodexx-and-charite-to-form-research-alliance-following-successful-clinical-proof-of-principle-for-molecular-genetic-based-preeclampsia-assay/ 2017-04-28T10:37:09+02:00 https://lifecodexx.com/lifecodexx-expands-its-praenatest-spectrum-and-reports-positive-reimbursement-decision-in-germany/ 2017-05-04T15:12:03+02:00 https://lifecodexx.com/lifecodexx-fuehrt-nahezu-6-000-praenatest-analysen-im-ersten-jahr-durch/ 2017-05-04T15:19:05+02:00 https://lifecodexx.com/lifecodexx-fuehrt-nahezu-6-000-praenatest-analysen-im-ersten-jahr-durch/ 2017-05-04T15:20:28+02:00 https://lifecodexx.com/?p=4593 2017-05-04T15:24:04+02:00 https://lifecodexx.com/4586/ 2017-05-04T15:27:07+02:00 https://lifecodexx.com/lifecodexx-ag-partners-with-lifecell-to-launch-rapid-and-affordable-non-invasive-prenatal-dna-testing-nipt-in-india-2/ 2017-06-07T13:45:08+02:00 https://lifecodexx.com/lifecodexx-ag-partners-with-lifecell-to-launch-rapid-and-affordable-non-invasive-prenatal-dna-testing-nipt-in-india-2/ 2017-06-07T13:45:33+02:00 https://lifecodexx.com/vereinbarung-einer-forschungsallianz-zwischen-lifecodexx-und-charite-nach-erfolgreicher-klinischer-machbarkeitsstudie-zu-molekulargenetischem-praeeklampsie-assay/ 2017-08-22T09:11:08+02:00 https://lifecodexx.com/lifecodexx-ag-hat-mit-dem-praenatest-die-praenataldiagnostik-in-den-letzten-5-jahren-nachhaltig-veraendert/ 2017-08-25T13:54:40+02:00 https://lifecodexx.com/nicht-invasive-praenatale-tests-nipt-werden-kassenleistung/ 2019-09-19T15:18:07+02:00 https://lifecodexx.com/praenatest-kassenleistung-ab-01-07-2022/ 2022-05-25T07:56:49+02:00 https://lifecodexx.com/praenatest-was-aendert-sich-mit-dem-kassenstart-am-1-juli/ 2024-01-03T15:16:38+01:00 https://lifecodexx.com/wp-content/uploads/2022/06/WM-1183-DE-011_Abrechnungshinweis.jpg